Mankind Pharma Limited — Important, 31-07-2025: General Updates

Mankind Pharma's board has declared an interim dividend of Rs. 1/- per equity share for the current financial year. This dividend is subject to tax at source (TDS). Shareholders should ensure their Permanent Account Number (PAN) is valid and linked with Aadhaar to avoid higher tax deductions. Resident shareholders can submit Form 15G/15H for nil TDS if eligible, while non-residents may provide Tax Residency Certificates for Double Taxation Avoidance Agreement benefits. To apply the correct TDS rate, all necessary documents must be submitted to the Registrar and Share Transfer Agent by August 07. Investors should consult tax advisors for personalized guidance.